The Parker Institute for Cancer Immunotherapy (PICI) is radically changing the way cancer research is done. Founded in 2016 through a $250 million gift from Silicon Valley entrepreneur and philanthropist Sean Parker, the San Francisco-based nonprofit is an unprecedented collaboration between the country's leading immunotherapy researchers and cancer centers, including Memorial Sloan Kettering Cancer Center, Stanford Medicine, the University of California, Los Angeles, the University of California, San Francisco, the University of Pennsylvania and The University of Texas MD Anderson Cancer Center. 

Research

Parker Institute for Cancer Immunotherapy

Sean Parker

Enjun Yang

Natalie Greco

Coltin Krauss

W. Dale Harding

Shane Corcoran

Sara Coblin

Kevin Marks

Ute Dugan

Tarak D. Mody

John Connolly

The Research and Development Team at the Parker Institute for Cancer Immunotherapy drives groundbreaking advancements in cancer immunotherapy through collaborative research. Comprising leading experts, the team focuses on designing and implementing innovative clinical trials, fostering partnerships across premier cancer centers, and translating scientific insights into effective treatments for patients. Their mission is to accelerate progress in the field by integrating diverse expertise and resources in the fight against cancer.

Research and Development Team

Leadership Team

Business Operations Team

Research and Development Team

About

Team members

Other teams at Parker Institute for Cancer Immunotherapy

Leadership Team

Business Operations Team